Viruses, Vol. 12, Pages 581: In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus
Viruses, Vol. 12, Pages 581: In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus
Viruses doi: 10.3390/v12050581
Authors:
Yejin Jang
Jin Soo Shin
Joo-Youn Lee
Heegwon Shin
Sang Jick Kim
Meehyein Kim
Influenza A virus, one of the major human respiratory pathogens, is responsible for annual seasonal endemics and unpredictable periodic pandemics. Despite the clinical availability of vaccines and antivirals, the antigenic diversity and drug resistance of this virus makes it a persistent threat to public health, underlying the need for the development of novel antivirals. In a cell culture-based high-throughput screen, a β2-adrenergic receptor agonist, nylidrin, was identified as an antiviral compound against influenza A virus. The molecule was effective against multiple isolates of subtype H1N1, but had limited activity against subtype H3N2, depending on the strain. By examining the antiviral activity of its chemical analogues, we found that ifenprodil and clenbuterol also had reliable inhibitory effects against A/H1N1 strains. Field-based pharmacophore modeling with comparisons of active and inactive compounds revealed the importance of positive and negative electrostatic patterns of phenyl aminoethanol derivatives. Time-of-addition experiments and visualization of the intracellular localization of nucleoprotein NP demonstrated that an early step of the virus life cycle w...
Source: Viruses - Category: Virology Authors: Yejin Jang Jin Soo Shin Joo-Youn Lee Heegwon Shin Sang Jick Kim Meehyein Kim Tags: Article Source Type: research
More News: Chemistry | Endemics | Flu Pandemic | H1N1 | H3N2 | Influenza | Influenza Vaccine | International Medicine & Public Health | Pandemics | Respiratory Medicine | Study | Swine Flu (H1N1) Vaccine | Vaccines | Virology